Search Results 501-510 of 17839 for Coagulation
Acceptable coagulation studies as demonstrated by prothrombin time (PT) and partial thromboplastin time (PTT) within normal limits (+/-15%); No clinically ...
AST (SGOT) and ALT (SGPT) ≤ 2.5 × ULN. Coagulation. INR or PT ≤ 1.5 × ULN unless participant is receiving anticoagulant therapy as long as PT or aPTT/PTT ...
Patients with coagulation problems and active bleeding in the last month prior to cycle 1 day 1 (peptic ulcer, epistaxis, spontaneous bleeding); Previous ...
... coagulation. In the Phase 2 portion of the trial only, subjects who have previously received treatment with an inhibitor of Isocitrate dehydrogenase protein ...
Subject must have adequate coagulation, renal, and hepatic function, per laboratory reference range at Screening. Exclusion Criteria: Exhibits evidence of ...
Adequate coagulation defined as. International normalized ratio (INR)/prothrombin time (PT) ≤ 1.5 x upper limit of normal. Exclusion Criteria: Patients with ...
... coagulation, Bleeding disorder, Benign hematologic condition, Autoimmune hemolytic anemia, Paroxysmal nocturnal hemoglobinuria, Myeloproliferative disorders ...
Have had a difficult time with previous colonoscopy procedures. • Are on anti-coagulant drugs. • Have a colon obstruction. • Prefer not to have a standard ...
Adequate coagulation function, defined by prothrombin time (PT)/international normalized ratio (INR), international normalized ration (INR) and partial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.